Eligible patients were those registered in the RHC-FOSP with confirmed diagnosis of prostate cancer (International Classification of Diseases C61) between January 2014 and December 2017, with ...

Ductal carcinoma of the prostate might be the primary diagnosis or an incidental finding mixed with acinar adenocarcinoma during pathologic examination.

[72] Atypical adenomatous hyperplasia can be difficult to distinguish from low-grade prostatic adenocarcinoma because both are located in the transition zone and show small acinar proliferation ...

Objective: To evaluate the influence of the delay on the risk of disease recurrence in patients with acinar adenocarcinoma of the prostate treated with RP. Method: Four hundred and twelve patients ...

In 2024, prostate cancer (PCa) remains the most common non-skin ... their Gleason score is secondary to the primary acinar carcinoma, for example 3 + 4, and while this would typically be a score ...

Lynparza for adult patients with deleterious or suspected deleterious germline or somatic homologous recombination repair (HRR) gene-mutated metastatic castration-resistant prostate ... cell carcinoma ...

EVEREST-2: A seamless phase 1/2 study of A2B694, a logic-gated Tmod chimeric antigen receptor T-cell (CAR T) therapy, in patients with pancreatic cancer (PANC) or other mesothelin (MSLN)-expressing ...

Cases of prostate cancer are on the rise in California, according to new research. A study by UC San Francisco (UCSF) included nearly 388,000 men who had prostate cancer between 2004 and 2021.

However, there is a lack of studies on its expression on prostatic carcinoma. In this study, the evaluation of MMP-26 reactivity by immunohistochemistry (IHC) was carried out in 150 paraffinized ...